Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLin, Guimiaoen
dc.contributor.authorChen, Tingen
dc.contributor.authorZou, Jinyunen
dc.contributor.authorWang, Yuchengen
dc.contributor.authorWang, Xiaomeien
dc.contributor.authorLi, Jiefengen
dc.contributor.authorHuang, Qijunen
dc.contributor.authorFu, Zicaien
dc.contributor.authorZhao, Yingyingen
dc.contributor.authorLin, Marie Chia-Mien
dc.contributor.authorXu, Gaixiaen
dc.contributor.authorYong, Ken-Tyeen
dc.identifier.citationLin, G., Chen, T., Zou, J., Wang, Y., Wang, X., Li, J., et al. (2017). Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells. Frontiers in Pharmacology, 8, 182-.en
dc.description.abstractRNA interfering (RNAi) using short interfering RNA (siRNA) is becoming a promising approach for cancer gene therapy. However, owing to the lack of safe and efficient carriers, the application of RNAi for clinical use is still very limited. In this study, we have developed cadmium sulphoselenide/Zinc sulfide quantum dots (CdSSe/ZnS QDs)-based nanocarriers for in vitro gene delivery. These CdSSe/ZnS QDs are functionalized with polyethyleneimine (PEI) to form stable nanoplex (QD-PEI) and subsequently they are used for siRNA loading which specially targets human telomerase reverse transcriptase (TERT). High gene transfection efficiency (>80%) was achieved on two glioblastoma cell lines, U87 and U251. The gene expression level (49.99 ± 10.23% for U87, 43.28 ± 9.66% for U251) and protein expression level (51.58 ± 7.88% for U87, 50.69 ± 7.59% for U251) of TERT is observed to decrease substantially after transfecting the tumor cells for 48 h. More importantly, the silencing of TERT gene expression significantly suppressed the proliferation of glioblastoma cells. No obvious cytotoxicity from these QD-PEI nanoplexes were observed over at 10 times of the transfected doses. Based on these results, we envision that QDs engineered here can be used as a safe and efficient gene nanocarrier for siRNA delivery and a promising tool for future cancer gene therapy applications.en
dc.description.sponsorshipASTAR (Agency for Sci., Tech. and Research, S’pore)en
dc.format.extent10 p.en
dc.relation.ispartofseriesFrontiers in Pharmacologyen
dc.rights© 2017 Lin, Chen, Zou, Wang, Wang, Li, Huang, Fu, Zhao, Lin, Xu and Yong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en
dc.subjectQuantum Dotsen
dc.subjectRNA Interferingen
dc.titleQuantum dots-siRNA nanoplexes for gene silencing in central nervous system tumor cellsen
dc.typeJournal Articleen
dc.contributor.schoolSchool of Electrical and Electronic Engineeringen
dc.description.versionPublished versionen
item.fulltextWith Fulltext-
Appears in Collections:EEE Journal Articles
Files in This Item:
File Description SizeFormat 
Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells.pdf6.35 MBAdobe PDFThumbnail

Citations 20

Updated on Sep 2, 2020

Citations 10

Updated on Mar 3, 2021

Page view(s) 50

Updated on May 21, 2022

Download(s) 50

Updated on May 21, 2022

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.